JSB Market Research: Nuclear Medicine Market and Radiopharmaceuticals - Global Trends & Forecast to 2017
The market of radiopharmaceuticals is dominated by diagnostic radioisotopes, comprising of SPECT and PET radioisotopes. The lions share of the SPECT market is taken up by Tc-99m, whereas the PET market is dominated by F-18FDG isotope.
The market of radiopharmaceuticals is dominated by diagnostic radioisotopes, comprising of SPECT and PET radioisotopes. The lions share of the SPECT market is taken up by Tc-99m, whereas the PET market is dominated by F-18FDG isotope.
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Table 59 Thyroid Spect <strong>Market</strong>, By Geography, 2010 – <strong>2017</strong> ($Million)<br />
Table 60 Neurology Spect <strong>Market</strong>, By Geography, 2010 – <strong>2017</strong> ($Million)<br />
Table 61 Other Spect Applications <strong>Market</strong>, By Geography, 2010 – <strong>2017</strong> ($Million)<br />
Table 62 <strong>Global</strong> Pet Application <strong>Market</strong>, 2010 – <strong>2017</strong> ($Million)<br />
Table 63 Oncology Pet <strong>Market</strong>, By Geography, 2010 – <strong>2017</strong> ($Million)<br />
Table 64 Cardiology Pet <strong>Market</strong>, By Geography, 2010 – <strong>2017</strong> ($Million)<br />
Table 65 Neurology Pet <strong>Market</strong>, By Geography, 2010 – <strong>2017</strong> ($Million)<br />
Table 66 Other Pet Applications <strong>Market</strong>, By Geography, 2010 – <strong>2017</strong> ($Million)<br />
Table 67 <strong>Global</strong> Radiopharmaceutical <strong>Market</strong> For Therapeutic Applications,2010 – <strong>2017</strong><br />
($Million)<br />
Table 68 Radiopharmaceutical <strong>Market</strong> For Therapeutic Applications, By Geography,2010 –<br />
<strong>2017</strong> ($Million)<br />
Table 69 Therapeutic Radiopharmaceutical <strong>Market</strong> For Thyroid Application, By<br />
Geography,2010 – <strong>2017</strong> ($Million)<br />
Table 70 Therapeutic Radiopharmaceutical <strong>Market</strong> For Bone Metastasis Application, By<br />
Geography, 2010 – <strong>2017</strong> ($Million)<br />
Table 71 Therapeutic Radiopharmaceutical <strong>Market</strong> For Lymphoma Application, By Geography,<br />
2010 – <strong>2017</strong> ($Million)<br />
Table 72 Therapeutic Radiopharmaceutical <strong>Market</strong> For Endocrine Application, By Geography,<br />
2010 – <strong>2017</strong> ($Million)<br />
Table 73 Therapeutic Radiopharmaceutical <strong>Market</strong> For Other Applications, By Geography, 2010<br />
– <strong>2017</strong> ($Million)<br />
Table 74 <strong>Global</strong> Stable Iso<strong>to</strong>pe <strong>Market</strong>, 2010 – <strong>2017</strong> ($Million)<br />
Table 75 Stable Iso<strong>to</strong>pe <strong>Market</strong>, By Geography, 2010 – <strong>2017</strong> ($Million)<br />
Table 76 Carbon Stable Iso<strong>to</strong>pe <strong>Market</strong>, By Geography, 2010 – <strong>2017</strong> ($Million)<br />
Table 77 Deuterium Stable Iso<strong>to</strong>pe <strong>Market</strong>, By Geography, 2010 – <strong>2017</strong> ($Million)<br />
Table 78 Oxygen Stable Iso<strong>to</strong>pe <strong>Market</strong>, By Geography, 2010 – <strong>2017</strong> ($Million)<br />
Table 79 Nitrogen Stable Iso<strong>to</strong>pe <strong>Market</strong>, By Geography, 2010 – <strong>2017</strong> ($Million)<br />
Table 80 Other Stable Iso<strong>to</strong>pe <strong>Market</strong>, By Geography, 2010 – <strong>2017</strong> ($Million)<br />
Table 81 <strong>Global</strong> Enriched Stable Iso<strong>to</strong>pe <strong>Market</strong>, By Application, 2010 – <strong>2017</strong> ($Million)<br />
Table 82 Stable Iso<strong>to</strong>pes <strong>Market</strong> For Medical Applications, By Geography, 2010 – <strong>2017</strong><br />
($Million)<br />
Table 83 Stable Iso<strong>to</strong>pes <strong>Market</strong> For <strong>Research</strong> Applications, By Geography, 2010 – <strong>2017</strong><br />
($Million)<br />
Table 84 Stable Iso<strong>to</strong>pes <strong>Market</strong> For Pharmaceutical Applications, By Geography, 2010 – <strong>2017</strong><br />
($Million)<br />
Table 85 Stable Iso<strong>to</strong>pes <strong>Market</strong> For Industrial Applications, By Geography, 2010 – <strong>2017</strong><br />
($Million)<br />
Table 86 Diagnostic <strong>Radiopharmaceuticals</strong> <strong>Market</strong>, By Geography, 2010 – <strong>2017</strong> ($Million)<br />
Table 87 Spect <strong>Radiopharmaceuticals</strong> <strong>Market</strong>, By Geography, 2010 – <strong>2017</strong> ($Million)<br />
Table 88 Pet <strong>Radiopharmaceuticals</strong> <strong>Market</strong>, By Geography, 2010 – <strong>2017</strong> ($Million)<br />
Table 89 North America: Radiopharmaceutical Diagnostic <strong>Market</strong>, By Technology, 2010 – <strong>2017</strong><br />
Email ID- contact@jsbmarketresearch.com<br />
Tel No- 91 2241236650<br />
Published by- http:/www.jsbmarketresearch.com/
Change language